TY - JOUR
T1 - Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients
AU - Simó, Rafael
AU - Higuera, Mónica
AU - García-Ramírez, Marta
AU - Canals, Francesc
AU - García-Arumí, José
AU - Hernández, Cristina
PY - 2008/8/1
Y1 - 2008/8/1
N2 - Objectives: To determine levels of apolipoprotein (apo) A-I and apo H in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR) and to examine whether apo A-I and apo H messenger RNA (mRNA) levels are overexpressed in the diabetic retina. Methods: Vitreous samples from 4 diabetic patients with PDR and 8 nondiabetic patients with macular hole were selected for proteomic analysis. Fourteen additional samples (7 from patients with PDR and 7 from patients with macular hole) were used for Western blot analysis. Fourteen postmortem eyes (7 from diabetic and 7 from nondiabetic donors) were used to perform quantitative real-time polymerase chain reaction analysis. Results: Intravitreous apo A-I and apo H levels were significantly higher in patients with PDR than in the control group. The apo A-I and apo H mRNA levels obtained from the retinas of diabetic donors were significantly higher than those obtained from nondiabetic donors. Retinal pigment epithelium was the main contributor to the differences. Conclusions: Levels of apo A-I and apo H are elevated in the vitreous fluid of diabetic patients with PDR. In addition, we provide the first evidence, to our knowledge, that a higher expression of apo A-I and apo H mRNAs exists in the diabetic retina. Clinical Relevance: The results of this study may be relevant to new treatment strategies aimed toward reducing the development of diabetic retinopathy. ©2008 American Medical Association. All rights reserved.
AB - Objectives: To determine levels of apolipoprotein (apo) A-I and apo H in the vitreous fluid of patients with proliferative diabetic retinopathy (PDR) and to examine whether apo A-I and apo H messenger RNA (mRNA) levels are overexpressed in the diabetic retina. Methods: Vitreous samples from 4 diabetic patients with PDR and 8 nondiabetic patients with macular hole were selected for proteomic analysis. Fourteen additional samples (7 from patients with PDR and 7 from patients with macular hole) were used for Western blot analysis. Fourteen postmortem eyes (7 from diabetic and 7 from nondiabetic donors) were used to perform quantitative real-time polymerase chain reaction analysis. Results: Intravitreous apo A-I and apo H levels were significantly higher in patients with PDR than in the control group. The apo A-I and apo H mRNA levels obtained from the retinas of diabetic donors were significantly higher than those obtained from nondiabetic donors. Retinal pigment epithelium was the main contributor to the differences. Conclusions: Levels of apo A-I and apo H are elevated in the vitreous fluid of diabetic patients with PDR. In addition, we provide the first evidence, to our knowledge, that a higher expression of apo A-I and apo H mRNAs exists in the diabetic retina. Clinical Relevance: The results of this study may be relevant to new treatment strategies aimed toward reducing the development of diabetic retinopathy. ©2008 American Medical Association. All rights reserved.
UR - https://www.scopus.com/pages/publications/49449108549
U2 - 10.1001/archopht.126.8.1076
DO - 10.1001/archopht.126.8.1076
M3 - Article
SN - 0003-9950
VL - 126
SP - 1076
EP - 1081
JO - Archives of Ophthalmology
JF - Archives of Ophthalmology
IS - 8
ER -